BioScrip, Inc.

The momentum for this stock is not very good. The stock will provide you with a reasonable dividend income. BioScrip, Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in BioScrip, Inc..
Log in to see more information.
BioScrip, Inc. engages in the provision of home infusion and home care management solutions. It part...
BIOS Fundamental Data by TradingView

News

BioPlus Acquisition announces intention to liquidate
BioPlus Acquisition announces intention to liquidate

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

BioPlus Acquisition, Avertix agree to terminate proposed business combination
BioPlus Acquisition, Avertix agree to terminate proposed business combination

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Avertix and BIOS Acquisition Corporation Mutually Agree to Terminate Proposed Business Combination
Avertix and BIOS Acquisition Corporation Mutually Agree to Terminate Proposed Business Combination

Globe Newswire EATONTOWN, N.J. and NEW YORK, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Avertix Medical, Inc. ( Avertix or the Company ), formerly known as Angel Medical Systems, Inc., a company focused on improving...\n more…

BioPlus Acquisition Corp. (NASDAQ:BIOS) Short Interest Update
BioPlus Acquisition Corp. (NASDAQ:BIOS) Short Interest Update

Ticker Report BioPlus Acquisition Corp. (NASDAQ:BIOS Get Free Report) was the recipient of a significant growth in short interest in the month of August. As of August 15th, there was short interest...\n more…

Heart & Rhythm Institute of Trinity and Avertix Announce Partnership to Improve Cardiac Care and Patient Monitoring
Heart & Rhythm Institute of Trinity and Avertix Announce Partnership to Improve Cardiac Care and Patient Monitoring

Globe Newswire The Avertix Guardian System, the first and only FDA approved implantable heart attack warning system, now available at the Heart & Rhythm Institute of Trinity, extending their commitment to redefining cardiac care in the Tampa, FL area Dr. Luis R. Annoni-Suau, MD, FACC and Dr. Carlos J. Bayron ...\n more…

Renown Cardiologist and Professor Ian T. Meredith, MD to Join Avertix Medical's Board of Directors
Renown Cardiologist and Professor Ian T. Meredith, MD to Join Avertix Medical's Board of Directors

Globe Newswire Recently served as Boston Scientific Executive Vice President and Global Chief Medical Officer Professor Meredith brings to Avertix over 35 years of cardiology experience andcommitment to advancing cardiac care EATONTOWN, N.J., July 17, 2023 (GLOBE NEWSWIRE) -- Avertix Medical, Inc. (Avertix or the ...\n more…